论文部分内容阅读
目的观察银杏胶囊联合缬沙坦辅助治疗肺心病心衰患者的疗效。方法将89例患者随机分为3组,其中对照组27例,使用常规治疗,治疗组Ⅰ30例在常规治疗的基础上加用缬沙坦,治疗组Ⅱ32例在治疗组Ⅰ的基础上联合银杏胶囊,观察3组疗效。结果治疗组与对照组临床症状均有改善,治疗组Ⅰ的有效率为76.7%,治疗组Ⅱ的有效率为84.4%,对照组为58.6%,治疗组改变较对照组明显,差异有统计学意义(P<0.05或P<0.01);治疗组在血气改善方面较对照组明显,差异有统计学意义(P<0.05或P<0.01);在改善心脏结构方面,治疗组比对照组更为有利,差异有统计学意义(P<0.01)。结论在常规治疗的基础上加用缬沙坦对肺心病心衰患者可取得良好的疗效,若联合使用银杏胶囊、缬沙坦,疗效更佳。
Objective To observe the curative effect of Ginkgo capsule combined with valsartan in the treatment of patients with cor pulmonale heart failure. Methods 89 patients were randomly divided into 3 groups, of which 27 cases in the control group, the use of conventional treatment, the treatment group Ⅰ30 patients on the basis of conventional treatment with valsartan, the treatment group Ⅱ 32 cases in the treatment group Ⅰ based on the combination of ginkgo Capsule, observe the effect of 3 groups. Results The clinical symptoms of both treatment group and control group were improved. The effective rate of treatment group Ⅰ was 76.7%, that of treatment group Ⅱ was 84.4%, and that of control group 58.6%. The changes of treatment group were more obvious than those of control group (P <0.05 or P <0.01). The improvement of blood gas in the treatment group was more obvious than that of the control group (P <0.05 or P <0.01). In improving the cardiac structure, the treatment group was more than the control group Favorable, the difference was statistically significant (P <0.01). Conclusion The addition of valsartan on the basis of routine treatment can achieve good results in patients with heart failure of pulmonary heart disease. If combined with ginkgo capsule and valsartan, the curative effect is better.